Quoin Pharmaceuticals, Ltd. (QNRX) has 6 SEC Form 4 insider filings on record in the last 90 days. That includes 4 insider purchases totalling $280K. Most recent filing: Sept. 1, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 1, 2026 filed Aug. 31, 2026 | Carter Denise P. Chief Operating Officer | +$99,991 | 30,735 | — | No | |
|
|
||||||
| Sept. 1, 2026 filed Aug. 31, 2026 | Myers Michael Chief Executive Officer | +$99,991 | 30,735 | — | No | |
|
|
||||||
| Sept. 1, 2026 filed Aug. 31, 2026 | Lawlor Sally Bridget Chief Financial Officer | +$49,991 | 15,366 | — | No | |
|
|
||||||
| Sept. 1, 2026 filed Aug. 31, 2026 | Culverwell Anthony James Director | +$29,992 | 9,219 | — | No | |
|
|
||||||
| Aug. 28, 2026 filed Aug. 27, 2026 | LANGER DENNIS Director | $177,850 | 34,534 | +159% | No | |
|
|
||||||
Showing the 5 most recent of 6 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free